Quoin Pharmaceuticals Files 8-K for Undisclosed Event

Ticker: QNRX · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1671502

Quoin Pharmaceuticals, Ltd. 8-K Filing Summary
FieldDetail
CompanyQuoin Pharmaceuticals, Ltd. (QNRX)
Form Type8-K
Filed DateJun 20, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, regulatory-filing, corporate-event

TL;DR

Quoin Pharma filed an 8-K for an event on 6/18, details TBD.

AI Summary

Quoin Pharmaceuticals, Ltd. filed an 8-K on June 20, 2025, reporting an "Other Event" that occurred on June 18, 2025. The filing does not provide specific details about the event itself, but it confirms the company's principal executive offices are located at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.

Why It Matters

This filing indicates a material event has occurred for Quoin Pharmaceuticals, though the nature of the event remains undisclosed in this report.

Risk Assessment

Risk Level: medium — The lack of specific details in the 8-K regarding the 'Other Event' creates uncertainty for investors.

Key Players & Entities

  • Quoin Pharmaceuticals, Ltd. (company) — Filer of the 8-K report.
  • June 18, 2025 (date) — Date of the earliest event reported.
  • June 20, 2025 (date) — Date the 8-K was filed.
  • 42127 Pleasant Forest Court, Ashburn, VA 20148-7349 (location) — Address of Quoin Pharmaceuticals' Principal Executive Offices.
  • Cellect Biotechnology Ltd. (company) — Former company name.
  • Cellect Biomed Ltd. (company) — Former company name.

FAQ

What specific event is reported in this 8-K filing?

The filing states 'Other Events' occurred on June 18, 2025, but does not provide specific details about the nature of these events.

When was this 8-K report filed with the SEC?

This 8-K report was filed on June 20, 2025.

What is the principal executive office address for Quoin Pharmaceuticals, Ltd.?

The principal executive offices are located at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.

Has Quoin Pharmaceuticals, Ltd. operated under any previous names?

Yes, the company was formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd.

What is the SEC file number for Quoin Pharmaceuticals, Ltd.?

The SEC file number is 001-37846.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.